Nanocarriers for natural polyphenol senotherapeutics

Area of Science:

• Cellular biology
• Gerontology
• Pharmacology

Background:

• Cellular senescence is a complex process linked to aging and disease.
• Current senolytic therapies face challenges like poor bioavailability and targeted delivery.
• Effective biomarkers for senescence are needed to evaluate therapeutic efficacy.

Purpose of the Study:

• To review senolytic polyphenols (fisetin, quercetin, resveratrol) and their properties.
• To explore the use of nanocarriers for enhanced polyphenol delivery.
• To discuss challenges and future directions in senolytic therapy.

Main Methods:

• Literature review of preclinical and clinical studies on senolytic polyphenols.
• Analysis of polyphenol properties, signaling pathways, and toxicities.
• Examination of nanocarrier strategies for senotherapeutic delivery.

Main Results:

• Fisetin, quercetin, and resveratrol show senolytic potential but have delivery limitations.
• Nanocarriers (polymer nanoparticles, lipid vesicles) can improve polyphenol stability and bioavailability.
• Examples of nanocarrier-mediated delivery to various cell types are presented.

Conclusions:

• Nanocarrier-based delivery systems offer a promising approach to overcome limitations of senolytic polyphenols.
• Further research is needed to develop reliable senescence biomarkers for therapy evaluation.
• Optimizing senolytic agents and nanocarriers can mitigate the negative impacts of senescence.